Radioimmunotherapy study of <sup>131</sup>I-labeled Atezolizumab in preclinical models of colorectal cancer.
Journal Information
Full Title: EJNMMI Res
Abbreviation: EJNMMI Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Radiology, Nuclear Medicine & Medical Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"additional file 1. fig s1c . the raw data"
"Declarations Ethics approval and consent to participateAll procedures were performed with the approval of the Institutional Animal Care and Use Committees of Jiangsu Institute of Nuclear Medicine. All methods were carried out in accordance with relevant guidelines and regulations. The study was carried out in compliance with the ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study was supported by grants from the National Key Research and Development Program of China (2019YFC0118100); National Natural Science Foundation of China (81671760, 81873910, and 82001860); and Beijing Friendship Hospital Seed Project, Capital Medical University (YYZZ201919)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025